LeMaitre Vascular, Inc. (LMAT)

AWM Investment Company Inc. lowered its position in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 10.3% in the second quarter, according to the company in its most recent filing with the SEC. Th...

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026....

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials....

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:...

The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders....

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences....

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials....

LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - Presi...

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago....

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarter...